Gil Roth12.19.13
Preclinical
Galectin publishes preclnical NASH data . . . read more
Phase I
NewLink launches F-I-H trial of renal immunotherapy . . . read more
Phase II
Pfizer completes enrollment in UC trial . . . read more
Phase III
Sandoz begins Humira biosimilar trial . . . read more
Vertex CF trial misses primary endpoint . . . read more
Filings
Daiichi Sankyo submits Lixiana sNDA in Japan . . . read more
Approvals
GSK, Theravance COPD treatment approved . . . read more
Lemtrada approved in Australia . . . read more
Galectin publishes preclnical NASH data . . . read more
Phase I
NewLink launches F-I-H trial of renal immunotherapy . . . read more
Phase II
Pfizer completes enrollment in UC trial . . . read more
Phase III
Sandoz begins Humira biosimilar trial . . . read more
Vertex CF trial misses primary endpoint . . . read more
Filings
Daiichi Sankyo submits Lixiana sNDA in Japan . . . read more
Approvals
GSK, Theravance COPD treatment approved . . . read more
Lemtrada approved in Australia . . . read more